SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-005311
Filing Date
2021-01-08
Accepted
2021-01-08 17:00:31
Documents
12
Period of Report
2021-01-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d200514d8k.htm   iXBRL 8-K 21870
  Complete submission text file 0001193125-21-005311.txt   143529

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20210107.xsd EX-101.SCH 3090
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20210107_lab.xml EX-101.LAB 18070
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20210107_pre.xml EX-101.PRE 11398
5 EXTRACTED XBRL INSTANCE DOCUMENT d200514d8k_htm.xml XML 3390
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 21518180
SIC: 2834 Pharmaceutical Preparations